` Comparison: ITCI vs MRK - Alpha Spread

ITCI
vs
MRK

Over the past 12 months, ITCI has underperformed MRK, delivering a return of 0% compared to the MRK's +39% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ITCI
MRK
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

ITCI Intrinsic Value
119.09 USD
Overvaluation 10%
Intrinsic Value
Price $131.87
MRK Intrinsic Value
114.89 USD
Overvaluation 5%
Intrinsic Value
Price $120.82
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Intra-Cellular Therapies Inc
NASDAQ:ITCI
131.87 USD
Merck & Co Inc
NYSE:MRK
120.82 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ITCI, MRK

ITCI
MRK
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Intra-Cellular Therapies Inc
Revenue
Merck & Co Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
ITCI, MRK

ITCI
MRK
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Merck & Co Inc
NYSE:MRK
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ITCI
91.6%
MRK
81.5%

Operating Margin

ITCI
-17.1%
MRK
41.2%

Net Margin

ITCI
-11%
MRK
28.1%

FCF Margin

ITCI
-10.8%
MRK
19%

ROE

ITCI
-8.6%
MRK
36.9%

ROA

ITCI
-7.1%
MRK
14.4%

ROIC

ITCI
-42.1%
MRK
21.4%

ROCE

ITCI
-13.2%
MRK
27.2%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
ITCI, MRK

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ITCI, MRK

Loading
ITCI
MRK
Difference
www.alphaspread.com

Performance By Year
ITCI, MRK

Loading
ITCI
MRK
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ITCI to other stocks
LLY
Eli Lilly and Co
More expensive
vs ITCI
JNJ
Johnson & Johnson
More expensive
vs ITCI
ROG
Roche Holding AG
Cheaper
vs ITCI
AZN
AstraZeneca PLC
More expensive
vs ITCI
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett